🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsCardiovascular OutcomesSOUL trial preliminary data — 6 month update

SOUL trial preliminary data — 6 month update

pete_RVA Mon, Oct 27, 2025 at 8:34 PM 9 replies 1,081 viewsPage 1 of 2
This thread is more than 7 months old. Information may be outdated. Consider searching for more recent discussions.
pete_RVA
Member
178
890
Dec 2024
Richmond, VA
Oct 27, 2025 at 9:59 PM#1

Hey everyone. I have been on semaglutide for 3 months now and wanted to get the community's take on something.

SOUL trial preliminary data — 6 month update

I have been reading through old threads but have not found exactly what I'm looking for. My situation: my doctor suggested soul trial preliminary data 6 month and I am not sure what to make of it.

Has anyone else dealt with this? What was your experience? My endo was not super helpful — just said to "monitor it" which is not exactly actionable advice lol.

Any input appreciated. Thanks in advance. 🙏

20 15mike_mod, SarahChen_PharmD, sarah.morrison and 17 others
Reply Quote Save Share Report
sarah.morrison
VIP Member
3,212
14,567
Jan 2024
California
Online
Oct 27, 2025 at 10:16 PM#2

SOUL trial preliminary data 6 month — I actually dealt with this exact situation a few weeks ago.

Short answer: it depends on your starting point. Longer answer: I wrote about my experience in the dosing forum if you want the full details.

Last edited: Oct 27, 2025 at 11:16 PM
39 16roxy_nash, tony_orlando, Dr.NephBHM_UK and 36 others
Reply Quote Save Share Report
amsterdam_pete
Senior Member
1,567
6,789
Feb 2024
Netherlands
Oct 27, 2025 at 10:33 PM#3
sarah.morrison said:
Short answer: it depends on your starting point

Completely agree with sarah.morrison. I would add that SOUL trial preliminary data 6 also has implications for long-term metabolic health that sometimes get overlooked in these discussions.

In my case, following a similar approach led to significant improvements compared to what I was doing before.

19 5CanadaChris, ZaraB_AL, JakeSmashed95 and 16 others
Reply Quote Save Share Report
JenPlateau
Member
234
890
Nov 2024
Missouri
Oct 27, 2025 at 10:50 PM#4

This thread is incredible for SOUL trial prelimina info. Better than most online groups.

7 23FitDadDave, RunnerRach, TrialNerd_Beth and 4 others
Reply Quote Save Share Report
julia.endo
Senior Member
1,890
9,012
Feb 2024
Cincinnati, OH
Oct 27, 2025 at 11:07 PM#5

As a pharmacist, I want to add some clinical context to this discussion on SOUL trial preliminary data 6 month.

Building on what pete_RVA said — the evidence base here is robust. The key publications to reference are from the FLOW program[1].

Key clinical points:

  1. Efficacy is dose-dependent and typically requires 4-5 weeks to reach steady state
  2. Side effect profile is predictable and usually manageable with standard protocols
  3. Monitoring should include baseline labs and follow-up at 3-month intervals
  4. Patient education significantly improves outcomes and adherence

Standard disclaimer: this is educational, not individualized medical advice.

References:
[1] See thread title for relevant study identification.
36 19chris_chi24, tampaLisa73, KarenAZ_mom and 33 others
Reply Quote Save Share Report

Similar Threads

SELECT trial: 20% MACE reduction — mechanistic deep dive7 replies
Semaglutide cardiovascular benefit independent of weight loss11 replies
STEP-HFpEF: semaglutide in heart failure with preserved EF15 replies
GLP-1 and arterial inflammation — hsCRP and IL-6 reduction data18 replies
Lp(a) on GLP-1 agonists — any impact on this risk factor?8 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register